Beyond Dryness: Why Sjögren’s Syndrome Requires Multiple Treatment Paths

Effective Sjögren’s management demands a strict separation between symptomatic relief for sicca and immunosuppression for ...
Business Wire

Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated ...

– Systemic sclerosis (SSc) is a rare disease that impacts up to 75,000 people in the United States – – Approximately 80% of SSc patients may be affected by interstitial lung disease (ILD), a ...